Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate
The FINANCIAL -- Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of ...
The FINANCIAL -- Medicago, a biopharmaceutical company headquartered in Quebec City, and GSK are pleased to announce the start of ...